Probiotics in Cancer Prevention, Updating the Evidence

Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion

Volumn , Issue , 2016, Pages 781-791

  Maleki, Davood ^a   Homayouni, Aziz ^b   Khalili, Leila ^b   Golkhalkhali, Babak ^c  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Anticarcinogenic properties; Cancer; Prevention; Probiotics; Treatment

Indexed keywords

EID: 84966936628     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-802189-7.00059-9     Document Type: Chapter

References (93)

1. American Cancer Society Cancer Facts & Figures 2009, American Cancer Society, Atlanta.
2. American Cancer Society, 2010. Cancer Glossary.
3. Agence Francaise de Sécurité Sanitaire des Aliments/French Food Safety Agency (AFSSA), 2005. Effects of Probiotics and Prebiotics on Flora and Immunity in Adults.
4. Anukam K.C., Reid G. Probiotics: 100 years (1907-2007) after Elie Metchnikoff's observations. Communicating Current Research and Educational Topics and Trends in Applied Microbiology 2007, 466-474. Formatex.org, Spain. A. Mendez-Vilas (Ed.).
5. Aureli P., Capurso L., Castellazzi A.M., Clerici M., Giovannini M., Morelli L., Poli A., Pregliasco F., Salvini F., Zuccotti G.V. Probiotics and health: an evidence-based review. Pharmacol. Res. 2011, 63:366-376.
6. Ayebo A.D., Angelo I.A., Shahani K.M. Effect of ingesting Lactobacillus acidophilus milk upon faecal flora and enzyme activity in humans. Milchwissenschaft 1980, 35:730-733.
7. Baharav E., Mor F., Halpern M., Weinberger A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J. Nutr. 2004, 134:1964-1969.
8. Bakker-Zierikzee A.M., Van Tol E.A.F., Kroes H., Alles M.S., Kok F.J., Bindels J.G. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr. Allergy Immunol. 2006, 17:134-140.
9. Bengmark S., Aherne S., Molin G., Jeppsson B. Intestina; colonising lactobacilii. J. Nutr. 1998, 14:585-594.
10. Biasco G., Paganelli G.M., Brandi G., Brillanti S., Lami F., Callegari C., Gizzi G. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum on rectal cell kinetics and fecal pH. Ital. J. Gastroenterol. 1991, 23:142.
11. Brawer R., Brisbon N., Plumb J. Obesity and cancer. Prim. Care 2009, 36:509-531.
12. De Roos N., Katan M. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am. J. Clin. Nutr. 2000, 71:405-411.
13. De Simone C., Vesely R., Bianchi Salvadori B., Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int. J. Immunother. 1993, 9:23-28.
14. DiBaise J.K., Zhang H., Crowell M.D., Krajmalnik-Brown R., Decker G.A., Rittmann B.E. Gut microbiota and its possible relationship with obesity. Mayo Clin. Proc. 2008, 83:460-469.
15. Duffy L.C., Zielezny M.A., Riepenhoff-Talty M., Dryja D., Sayahtaheri-Altaie S., Griffiths E., Ruffin D., Barrett H., Rossman J., Ogra P.L. Effectiveness of Bifidobacterium bifidum in experimentally induced MRV infection: dietary implications in formulas for newborns. Endocr. Regul. 1993, 27(4):223-229.
16. Ebert M.N., Klinder A., Peters W.H., Schaferhenrich A., Sendt W., Scheele J., et al. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTMs by butyrate. Carcinogenesis 2003, 10:1637-1644.
17. Ewaschuk J.B., Walker J.W., Diaz H., Madsen K.L. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J. Nutr. 2006, 136:1483-1487.
18. FAO/WHO, 2001. FAO/WHO 'Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria'. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, October.
19. Friend B.A., Farmer R.E., Shahani K.M. Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich ascites tumor. Milchwissenschaft 1982, 37:708-710.
20. Galdeano C.M., Leblanc A.M., Vinderola G., Bonet M.E., Perdigon G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 2007, 14:485-492.
21. Garcia Vilela E., De Lourdes De Abreu Ferrari M., Oswaldo Da Gama Torres H., Guerra Pinto A., Carolina Carneiro Aguirre A., Paiva Martins F., Marcos Andrade Goulart E., Sales Da Cunha A. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand. J. Gastroenterol. 2008, 43(7):842-848.
22. Gibson G.R., MacFarlane G.T. Intestinal bacteria and disease. Human Health: The Contribution of Microorganisms 1994, 53-62. Springer-Verlag, London. S.A.W. Gibson (Ed.).
23. Goldin B.R., Gorbach S.I. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr. 1984, 39:756-761.
24. Goldin B.R., Gualtieri L.J., Moore R.P. The effect of Lactobacillus GG on the initiation and promotion of DMH induced intestinal tumors in the rat. Nutr. Cancer 1996, 25:197-204.
25. Grant B.L. Nutrition in Cancer Treatment: Continuum of Care 2012, Nutrition Dimension/Gannett Education. third ed.
26. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003, 361:512-519.
27. Haukioja A. Probiotics and oral health. Eur. J. Dent. 2010, 4:348-355.
28. Hayatsu H., Hayatsu T. Suppressing effect of Lactobacillus caseia dministration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett. 1993, 73:173-179.
29. Holzapfel W.H., Habere P., Geisen R., Björkroth J., Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am. J. Clin. Nutr. 2001, 73(2):365-373.
30. Homayouni A. Therapeutical Effects of Functional Probiotic, Prebiotic and Synbiotic Foods 2008, Tabriz University of Medical Sciences, Tabriz, pp. 30-32.
31. Homayouni A. Letter to the editor. Food Chem. 2009, 114:1073.
32. Homayouni A., Ejtahed H.S. The effect of probiotics in prevention and treatment of gastrointestinal disorders: a review. J. Microbiol. Biotechnol. 2009, 2:53-60.
33. Homayouni A., Azizi A., Ehsani M.R., Yarmand M.S., Razavi S.H. Effect of microencapsulation and resistant starch on the probiotic survival and sensory properties of synbiotic ice cream. Food Chem. 2008, 111:50-55.
34. Homayouni A., Ehsani M.R., Azizi A., Razavi S.H., Yarmand M.S. Spectrophotometrically evaluation of probiotic growth in liquid media. Asian J. Chem. 2008, 20:2414-2420.
35. Homayouni A., Payahoo L., Azizi A. Effects of probiotics on lipid profile: a review. Am. J. Food Technol. 2012, 7:251-265.
36. Homayouni A., Azizi A., Javadi M., Mahdipour S., Ejtahed H. Factors influencing probiotic survival in ice cream: a review. Int. J. Dairy Sci. 2012, 7:1-10.
37. Hosono A., Ozawa A., Kato R., Ohnishi Y., Nakanishi Y., Kimura T., Nakamura R. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells. Biosci. Biotechnol. Biochem. 2003, 67:758-764.
38. Isolauri E., Kaila M., Arvola T., et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr. Res. 1993, 33:548-553.
39. Isolauri E., Kaila M., Mykkänen H., Ling W.H., Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig. Dis. Sci. 1994, 39:2595-2600.
40. Kaila M., Isolauri E., Soppi E., Virtanen E., Laine S., Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human lactobacillus strain. Pediatr. Res. 1992, 32:141-144.
41. Kashfi K. Anti-inflammatory agents as cancer therapeutics. Adv. Pharmacol. 2009, 57:31-89.
42. Kato I., Kobayashi S., Yokokura T., Mutai M. Antitumor activity of Lactobacillus casei in mice. Gann 1981, 72:517-523.
43. Kim Y., Lee D., Kim D., Cho J., Yang J., Chung M., Kim K., Ha N. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch. Pharm. Res. 2008, 31:467-468. PubMed: 18449504.
44. Kim Y., Lee D., Kim D., Cho J., Yang J., Chung M., Kim K., Ha N. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch. Pharm. Res. 2008, 468-473.
45. Klampfer L., Huang J., Sasazuki T., Shirasawa S., Augenlicht L. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol. Cancer Res. 2003, 1:855-862.
46. Kohwi T., Imai K., Tamura A., Hashimoto Y. Antitumor effect of Bifidobacterium infantis in mice. Gann 1978, 69:613-618.
47. Kulkarni N., Reddy B.S. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane induced aberrant crypt foci formation and faecal bacterial β-glucuronidase. Proc. Soc. Exp. Biol. Med. 1994, 207:278-283.
48. Lidbeck A., Geltner Allinger U., Orrhage K.M., Ottova L., Brismar B., Gustafsson J.A., Rafter J.J., Nord C.E. Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microb. Ecol. Health Dis. 1991, 4:81-88.
49. Lidbeck A., Overvik E., Rafter J., Nord C.E., Gustafsson J.A. Effect of Lactobacillus acidophilus supplements on mutagen excretion in feces and urine in humans. Microb. Ecol. Health Dis. 1992, 5:59-67.
50. Lidbeck A., Nord C.E., Gustafsson J.A., Rafter J. Lactobacilli, anticarcinogenic activities and human intestinal microflora. Eur. J. Cancer Prev. 1992, 1:341-353.
51. Ling W.H., Korpela R., Mykkanen H., Salminen S., Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J. Nutr. 1994, 124:18-23.
52. Lourens-Hattingh A., Viljoen B.C. Yogurt as probiotic carrier food. Int. Dairy J. 2001, 11:1-17.
53. Mack D.R., Michail S., Wei S., McDougall L., Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 1999, 276:941-950.
54. Mack D.R., Ahrne S., Hyde L., Wei S., Hollingsworth M.A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003, 52:827-833.
55. Mai V. Dietary modification of the intestinal microbiota. Nutr. Rev. 2004, 62:235-242.
56. Majarmaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997, 99:179-186.
57. Malhotra S.L. Dietary factors in a study of colon cancer from cancer registry, with special reference to the role of saliva, milk, and fermented milk products and vegetable fibre. Med. Hypotheses 1977, 3:122-134.
58. Marteau P., Pochart P., Flourie B., Pellier P., Santos L., Desjeux J.-H., Rambaud J.-C. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am. J. Clin. Nutr. 1990, 52:685-688.
59. Matsumoto M., Benno Y. Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2004, 568:147-153.
60. McFarland L. A review of the evidence of health claims for biotherapeutic agents. Microb. Ecol. Health Dis. 2000, 12:65-76.
61. Miettinen M., Vuopio-Varkila J., Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 1996, 64:5403-5405.
62. National Cancer Institute (NCI), 2010. Cancer Bulletin-Cost of Cancer Care Has Doubled in the Past 20 Years.
63. O'Keefe S.J. Nutrition and colonic health: the critical role of the microbiota. Curr. Opin. Gastroenterol. 2008, 24:51-58.
64. Orlando A., Messa C., Linsalata M., Cavallini A., Russo F. Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol. Immunotoxicol. 2009, 31:108-116. PubMed: 19234959.
65. Ouwehand A.C. Antiallergic effects of probiotics. J. Nutr. 2007, 137:794-797.
66. Park E., Jeon G.I., Park J.S., Paik H.D. A probiotic strain of Bacillus polyfermenticus reduces DMH-induced precancerous lesions in F344 male rat. Biol. Pharm. Bull. 2007, 30:569-574.
67. Pessi T., Sütas Y., Saxelin M., Kallioinen H., Isolauri E. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl. Environ. Microbiol. 1999, 65:475-478.
68. Pool-Zobel B.L., Neudecker C., Domizlaff I., Ji S., Schillinger U., Rumney C., Moretti M., Vilarini I., Scassellati-Sforzolini R., Rowland I. Lactobacillus- and Bifidobacterium mediated antigenotoxicity in the colon of rats. Nutr. Cancer 1996, 26:365-380.
69. Pronio A., Montesani C., Butteroni C., Vecchione S., Mumolo G., et al. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm. Bowel Dis. 2008, 14:662-668.
70. Rafter J. Probiotics and colon cancer. Best Pract. Res. Clin. Gastroenterol. 2003, 17:849-859.
71. Reddy B.S., Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res. 1993, 53:3914-3918.
72. Rowland I.R., Rumney C.J., Coutts J.T., Lievense L.C. Effect of Bifidobacterium longum and inulin on gut bacteria metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998, 19:281-285.
73. Salgado R., Benoy I., Weytjens R., Van Bockstaele D., Van Marck E., Huget P., Hoylaerts M., Vermeulen P., Dirix L.Y. Arterio-venous gradients of IL-6, plasma and serum VEGF and d-dimers in human cancer. Br. J. Cancer 2002, 87:1437-1444.
74. Salminen S., Bouley C., Boutron-Ruault M.C., et al. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 1998, 80:147-171.
75. Salminen S., Gorbach S., Lee Y., Benno Y. Human studies on probiotics: what is it really proven today?. Lactic Acid Bacteria: Microbiology and Functional Aspects 2004, 515-530. Marcel Dekker Inc, New York, Revised and Expanded. third ed. S. Salminen, A. von Wright, A. Ouwehand (Eds.).
76. Sanders M.E. Summary of probiotic activities of Bifidobacterium lactis HN019. J. Clin. Gastroenterol. 2006, 40:776-783.
77. Sengupta S., Muir J.G., Gibson P.R. Does butyrate protect from colorectal cancer?. J. Gastroenterol. Hepatol. 2006, 21:209-218.
78. Shahani K.M., Ayebo A.D. Role of dietary lactobacilli in gastrointestinal microecology. Am. J. Clin. Nutr. 1980, 33:2448-2457.
79. Shu Q., Lin H., Rutherfurd K.J., Fenwick S.G., Prasad J., Gopal P.K., Gill H.S. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol. Immunol. 2000, 44:213-222.
80. Singh J., Rivenson A., Tomita M., Shimamura S., Ishibashi N., Reddy B.S. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997, 18:833-841.
81. Sivieri K., Spinardi-Barbusan A.L.T., Barbisan L.F., Bedani R., Pauly N.D., Carlos I.Z., Benzatti F., Vendramini R.C., Rossi E.A. Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male Wistar rats. Eur. Food Res. Technol. 2008, 228:231-237.
82. Soccol C.R., de Souza Vandenberghe L.P., Spier M.R., Medeiros A.B.P., Yamaguishi C.T., et al. The potential of probiotics: a review. Food Technol. Biotechnol. 2010, 48:413-434.
83. Songisepp E., Kullisaar T., Hutt P., Elias P., Brilene T., Zilmer M., Mikelsaar M. A new probiotic cheese with antioxidative and antimicrobial activity. J. Dairy Sci. 2004, 87:2017-2023.
84. Sultan A., Durrani F.R., Suhail S.M., Ismail M., Durrani Z., Chand N. Comparative effect of yogurt as probiotics on the performance of broiler chicks. Pak. J. Biol. Sci. 2006, 9:88-92.
85. Sütas Y., Soppi E., Korhonen H., et al. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J. Allergy Clin. Immunol. 1996, 98:216-224.
86. Tappenden K.A., Deutsch A.S. The physiological relevance of the intestinal microbiota-contributions to human health. J. Am. Coll. Nutr. 2007, 26:679-683.
87. Urbanska A.M., Bhathena J., Martoni C., Prakash S. Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice. Dig. Dis. Sci. 2009, 54:264-273. PubMed:18633708.
88. Wachtershauser A., Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur. J. Nutr. 2000, 39:164-171.
89. Weston S., Halbert A., Richmond P., Prescott S.L. Effects of probiotics on topic dermatitis: a randomised controlled trial. Arch. Dis. Child. 2005, 90:892-897.
90. Wilson R.A., Zolnai A., Rudas P., Frenyo L.V. T-cell subsets in blood and lymphoid tissues obtained from fetal calves, maturing calves, and adult bovine. Vet. Immunol. Immunopathol. 1996, 53:49-60.
91. Wong C.S., Sengupta S., Tjandra J.J., Gibson P.R. The influence of specific luminal factors on the colonic epithelium: high-dose butyrate and physical changes suppress early carcinogenesis events in rats. Dis. Colon Rectum 2005, 48:549-559.
92. Xue H., Sawyer M.B., Wischmeyer P.E., Baracos V.E. Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. JPEN 2011, 35:74-90.
93. Yeo S.K., Liong M.T. Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavons by probiotics in soymilk supplemented with prebiotics. Int. J. Food Sci. Nutr. 2010, 61:161-168.